Skip to main content
. 2021 Jul 23;100(29):e26737. doi: 10.1097/MD.0000000000026737

Figure 4.

Figure 4

Survival analysis after the development of cutaneous metastasis in breast and non-breast cancer patients. Median overall survival did not differ significantly (8.79 vs 9.21 months, P = .613).